In Vitro and In Vivo Activities of 2,3-Diarylsubstituted Quinoxaline Derivatives against Leishmania amazonensis

Leishmaniasis is endemic in 98 countries and territories worldwide. The therapies available for leishmaniasis have serious side effects, thus prompting the search for new therapies. The present study investigated the antileishmanial activities of 2,3-diarylsubstituted quinoxaline derivatives against...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Antimicrob Agents Chemother
Auteurs principaux: Kaplum, Vanessa, Cogo, Juliana, Sangi, Diego Pereira, Ueda-Nakamura, Tânia, Corrêa, Arlene Gonçalves, Nakamura, Celso Vataru
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2016
Sujets:
Mechanisms of Action: Physiological Effects
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4879393/
https://ncbi.nlm.nih.gov/pubmed/27001812
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02582-15
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires